ICM - Industrie Consult Munich

Introduction: Characteristics of the Active Ingredient ( Summary )
Topical Application
Chemically and physically well characterized
Biodegradable – no environmental risks
Known Mechanism of Action
Broad Spectrum of Efficacy; the substance has
bactericidal
virucidal and
fungicidal properties
No Formation of Resistance of Microorganisms
Suitable for Therapy of Poly-infections
Well tolerated by Skin and Mucosa
No allergic potential
No systemic toxic risks
No negative influence on wound healing
No mutagenic or carcinogenic effects
Galenical formulations ( ointment and adhesive ointment ) are without any preservatives
Estimated sales potential worldwide is several billion $

Cooperation Offer
We want to offer to you a cooperation concerning the above topic. The patent claims are summarized in Enclosure A. The active ingredient is of pharmaceutical quality with proven stability and well characterized concerning chemical, physical and toxicological properties; the substance shows a broad spectrum of virucidal, bactericidal and fungicidal properties; it has no mutagenic effects and is well tolerated concerning skin and mucosa.
The main goal of the invention is to use the active ingredient for the topical treatment of diseases of skin and mucosa, which lead or can lead to efflorescences (primary and secondary skin lesions).
Considering the primary skin lesions* ( Macules, patches, papules, plaques, nodules, tumors, vesicles, bullae, pustules, wheals, purpura, petechiae, ecchymoses, teleangiectasia) together with the secondary skin lesions* ( Scales, crusts, erosions, ulcers, excoriations, lichenification, atrophies, scars) {* source: "THE MERCK MANUAL of Diagnosis and Therapy",17th edition}, you can imagine the broad spectrum of indications concerning skin and mucosa.
The case reports are listed up in Enclosure B; the successful therapy of neurodermitis with viral superinfection is documented in
Enclosure C.
Taking into consideration the primary and secondary skin lesions in connection with the organs and tissues listed up in claim No. 6
Enclosure A, a broad field of applications concerning skin and mucosa is opened.
We have summed up these diseases according to the above mentioned MERCK MANUAL:
Pruritis; Dermatitis; Bacterial, Fungal, Viral and Parasitic Skin Infections; Disorders of Hair Follicles and Sebaceous Glands; Scaling Papular Diseases; Inflammatory Reactions, Reactions to Sunlight; Bullous Diseases; Disorders of Cornification; Pressure Sores; Pigmentation Disorders; Disorders of Sweating; Benign Tumors; Lesions or Disorders concerning the Lips, the Mouth and the Tongue, the Eyes and the Ears.
The patent applications filed  Enclosure D.